INFOS !
  • NEW ADDRESS: The management team of ERN-EYE is moving! Starting from March 19, you can find us at 1 Rue Eugène Boeckel, 67000 Strasbourg.

Accessibility and reading comfort

Text size

Light/Dark mode

Lines vertical spacing

Trouble using our website?
Contact us

In this page

Clinical Trial

NCT03079141 Unknown
SPECT

Half-dose photodynamic therapy versus eplerenone treatment in chronic centralserous chorioretinopathy.

Phase 4
Interventional

Disease

Disease type

Paediatric clinical trials

Orphan drug recognition

NA

Patient type

Adult

Children

Inclusion / Exclusion

Opening date

20/02/2017

Closing date

20/02/2019

Inclusion criteria :

More

Exclusion criteria :

More

Funding

other

Members involved

Main investigators

Pr Camiel BOON

Representative

Netherlands

Anterior Segment Rare Eye Diseases (WG4), Genetic Diagnostics (TWG6), National Integration (TWG9), Pediatric Ophthalmology Rare Diseases (WG3), Registries & Epidemiology (TWG7), Research (TWG8), Retinal Rare Eye Diseases (WG1)
Working Group Leader
See more

Others investigators

Pr Carel HOYNG

Representative

Netherlands

Genetic Diagnostics (TWG6), Registries & Epidemiology (TWG7), Research (TWG8), Retinal Rare Eye Diseases (WG1)
See more

ERN EYE member investigating site

HCP : Principal investigators

HCP : Others investigators